Reaction

Hip Dysplasia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 220 reports · 2 co-occurring drugs

As of the last recalculation, Hip Dysplasia appears in 220 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CLOBAZAM (PRR 71.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Clobazam1771.371.4
Palivizumab318.718.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.